GSK submits first regulatory application for daprodustat in Japan for patients with renal anaemia due to chronic kidney disease

Issued: London, UK GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the submission of a Japanese New Drug Application (JNDA) to the Ministry of Health, Labour and Welfare seeking marketing approval for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for the treatment of patients with renal anaemia due to chronic kidney disease (CKD). Dr Hal Barron, Chief Scientific Officer and...

READ MORE GSK submits first regulatory application for daprodustat in Japan for patients with renal anaemia due to chronic kidney disease

Oxygen delivery and haemoglobin

Abstract Oxygen must be transported effectively from the atmosphere to the tissues in order to sustain normal metabolism. An understanding of oxygen delivery is therefore central to the management of patients during anaesthesia, resuscitation and during critical illness. This review deals specifically with the transport of oxygen from the lungs to non-pulmonary tissues. Key points Oxygen is carried in arterial...

READ MORE Oxygen delivery and haemoglobin